Patents Assigned to DERMADIS SA
  • Use of serine protease inhibitors in the treatment of skin diseases
    Patent number: 11793864
    Abstract: This invention relates to therapeutic compounds which are inhibitors of serine proteases, to pharmaceutical compositions thereof and to their use in the treatment of the human or animal body. More specifically, the present invention relates to a method for the treatment, diagnosis or prognosis of skin diseases comprising the administration to a subject in need thereof of a therapeutically effective amount of a Serine protease inhibitor.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: October 24, 2023
    Assignees: DERMADIS SA, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: David Deperthes, Christoph Kundig, Alain Hovnanian, Celine Deraison
  • USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES
    Publication number: 20190183989
    Abstract: This invention relates to therapeutic compounds which are inhibitors of serine proteases, to pharmaceutical compositions thereof and to their use in the treatment of the human or animal body. More specifically, the present invention relates to a method for the treatment, diagnosis or prognosis of skin diseases comprising the administration to a subject in need thereof of a therapeutically effective amount of a Serine protease inhibitor.
    Type: Application
    Filed: December 12, 2018
    Publication date: June 20, 2019
    Applicants: DERMADIS SA, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: David Deperthes, Christoph Kundig, Alain Hovnanian, Celine Deraison
  • USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES
    Publication number: 20110130338
    Abstract: This invention relates to therapeutic compounds which are inhibitors of serine proteases, to pharmaceutical compositions thereof and to their use in the treatment of the human or animal body. More specifically, the present invention relates to a method for the treatment, diagnosis or prognosis of skin diseases comprising the administration to a subject in need thereof of a therapeutically effective amount of a Serine protease inhibitor.
    Type: Application
    Filed: January 21, 2009
    Publication date: June 2, 2011
    Applicants: DERMADIS SA, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: David Deperthes, Christoph Kundig, Alain Hovnanian, Celine Deraison